Thank you for attending the 2019 event.
We look forward to seeing you again 26-28 May 2020!
Scientific Director, Janssen Clinical Innovation Patient Data for Research (JCI-PDR), Janssen Pharm R&D. A former UK NHS healthcare & voluntary sector professional working in the pharmaceutical and diagnostics industry with a prior specialty in the blood borne virus market based on a professional heritage in the viral hepatitis, liver disease & HIV fields spanning thirty years, inclusive of ten years in the voluntary sector and being a Dept. of Health advisor. Formerly working for Roche, Gilead, Novartis, and now Janssen, he has focused previously on strategic marketing for new diagnostic solutions for personalized medicine via bio-informatic tools, health information technologies and biomarkers in infectious or chronic diseases, with a particular emphasis on real world data. He worked on the IMI European Medical Information Framework (EMIF) as the EFPIA Platform Co-Coordinator, and associated within Janssen developing digital cohorts, and also integration of real world evidence programmes, and he is now the Project Leader for the European Health Data & Evidence Network (EHDEN) IMI2 project, as well as consulting on other IMI2 projects, such as blockchain enabled healthcare, Patient Generated Data (H2O), and others, and working on the sustainability of EMIF projects in Alzheimer’s diseases, and a confederation of real world data sources